Counterfeit prescription drugs are on the rise, and the Drug Supply Chain Security Act (DSCSA) is intended to protect their unintentional distribution to patients. Take this course to learn inventory and documentation practices that authenticate sources of medications, protect against product integrity issues, and ensure patient access to safe medications. 

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. Recognize the regulatory agencies that register or license supply chain entities
2. Identify specific regulations that apply to the sale and purchase of prescription products
3. Describe the different types of suppliers, including limitations on their ability to obtain and/or sell products
4. Authenticate suppliers as legitimate
5. Identify risky situations that increase the chance of receiving counterfeit or illegitimate products
6. Discuss health-system use of obtaining products outside of a wholesaler or manufacturer (white/brown bagging, etc.)
7. Demonstrate when obtaining products from another pharmacy is allowed
8. Calculate days supply or turn rates of inventory
9. Describe different types of inventory management strategies
10. Explain the process to perform and document inventories of controlled substances
11. Recognize suspicious signs that received product may be diverted or illegitimate
12. Assess documentation including transaction data to determine product authenticity
13. Demonstrate appropriate steps to take when a product is suspicious and may be illegitimate 

Denise Frank, BPharm, RPh, FACA
Principal
Frank Consulting, LLC

Denise Frank has no relevant financial relationships to disclose. 

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: July 1, 2022
Planned Expiration Date: July 1, 2025

Copyright 2022, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.

RV2-4.24